Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Natumin Pharma AB
AB
Active
Org 5564747748
Snickaregatan 10, 566 33
Habo
Manufacture of perfume and toilet preparations
·
NACE 2042
Est. 1993 · 32 years old
24 employees
Monitor
Share
Sweden
/
Companies
/
Manufacture of perfume and toilet preparations
/
Natumin Pharma AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
20M
39M
59M
78M
59M
2020
62M
2021
66M
2022
68M
2023
67M
2024
EBITDA
SEK millions
0M
-3M
-5M
-8M
-10M
-8M
2020
-6M
+25%
2021
-3M
+50%
2022
-1M
+67%
2023
-3M
-200%
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
59 233
62 169
65 733
67 728
67 056
Staff expenses
—
—
—
—
—
EBITDA
−8 091
−6 144
−2 600
−743
−3 310
Depreciation & amort.
−1 682
−1 511
−884
−610
−681
EBIT
−9 773
−7 655
−3 484
−1 353
−3 991
Net financials
−236
−383
−513
3 319
−1 178
Profit before tax
−2 990
−3 306
−3 997
6 788
−869
Tax
−0
−0
−0
−0
−1
Net profit
−2 990
−3 306
−3 997
6 788
−870
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
44 749
51 392
54 904
61 324
116 406
Equity
26 869
23 563
19 566
26 354
25 484
Long-term debt
10 337
7 146
12 111
16 168
72 318
Short-term debt
7 543
20 683
23 228
18 802
18 604
Total debt
17 880
27 829
35 339
34 970
90 922
Financial ratios
5-year trend
EBITDA margin
-4.9%
This company
15.8%
Market median
-131% vs market
2020
2024
Equity ratio
21.9%
This company
38.2%
Market median
-43% vs market
2020
2024
Return on equity
-3.4%
This company
18.4%
Market median
-118% vs market
2020
2024
Net profit margin
-1.3%
This company
8.1%
Market median
-116% vs market
2020
2024
Asset turnover
0.58×
This company
1.12×
Market median
-48% vs market
2020
2024
Debt / equity
3.57×
This company
0.62×
Market median
-476% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Natumin Pharma AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
